AbCellera Biologics Inc.

Historical 13F Holders

Symbol
ABCL
CUSIP
00288U106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 00288U106 since 12/18/2024, largest first.

Filer % of Class Filed
Baker Bros. Advisors LP 13G/A
10.8% 5/7/2026
Event 4/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Baillie Gifford & Co 13G/A 4.4% 10/9/2024
Event 9/30/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 64 13.5 M $191M
2026 Q2 151 116 M $909M
2026 Q1 139 124 M $434M
2025 Q4 146 108 M $371M
2025 Q3 146 104 M $525M
2025 Q2 130 108 M $371M
2025 Q1 131 125 M $280M
2024 Q4 147 114 M $334M
2024 Q3 140 106 M $274M
2024 Q2 150 114 M $338M
2024 Q1 157 121 M $547M
2023 Q4 147 119 M $681M
2023 Q3 139 120 M $552M
2023 Q2 171 125 M $809M
2023 Q1 185 130 M $981M
2022 Q4 205 128 M $1.30B
2022 Q3 193 122 M $1.21B
2022 Q2 167 118 M $1.26B
2022 Q1 134 113 M $1.10B
2021 Q4 128 115 M $1.63B
2021 Q3 121 98.7 M $1.98B
2021 Q2 118 90.6 M $1.99B
2021 Q1 87 71.2 M $2.42B
2020 Q4 63 68.1 M $2.74B